BRADLEY FOSTER & SARGENT INC/CT – Abbott Laboratories Transaction History
BRADLEY FOSTER & SARGENT INC/CT portfolio value:
$33.39M
portfolio value
BRADLEY FOSTER & SARGENT INC/CT quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.50% | -1.72K shares | -4.29M | $96.76 | 345.12K |
| Q2 2022 | share | Decrease | -0.89% | -3.12K shares | -3.73M | $108.65 | 346.84K |
| Q1 2022 | share | Increase | +2.11% | 7.23K shares | -6.81M | $118.36 | 349.96K |
| Q4 2021 | share | Increase | +3.68% | 12.15K shares | 9.18M | $141 | 342.73K |
| Q3 2021 | share | Decrease | -2.10% | -7.07K shares | -93K | $117.68 | 330.57K |
| Q2 2021 | share | Decrease | -0.76% | -2.59K shares | -1.63M | $115.05 | 337.65K |
| Q1 2021 | share | Decrease | -3.59% | -12.66K shares | 2.13M | $118.49 | 340.25K |
| Q4 2020 | share | Decrease | -0.05% | -164 shares | 215K | $107.81 | 352.91K |
| Q3 2020 | share | Decrease | -2.46% | -8.9K shares | 9.86M | $106.81 | 353.08K |
| Q1 2020 | share | Decrease | -0.69% | -2.50K shares | -3.09M | $76.84 | 361.98K |
| Q4 2019 | share | Decrease | -0.63% | -2.29K shares | 970K | $84.23 | 364.48K |
| Q3 2019 | share | Decrease | -1.05% | -3.90K shares | -486K | $80.81 | 366.78K |
| Q2 2019 | share | Decrease | -1.70% | -6.40K shares | 1.03M | $80.92 | 370.69K |
| Q1 2019 | share | Decrease | -1.14% | -4.34K shares | 2.55M | $76.6 | 377.09K |
| Q4 2018 | share | Decrease | -3.35% | -13.23K shares | -1.36M | $68.98 | 381.44K |
| Q3 2018 | share | Decrease | -6.12% | -25.71K shares | 3.31M | $69.69 | 394.67K |
| Q2 2018 | share | Increase | +2.41% | 9.90K shares | 1.04M | $57.68 | 420.39K |
| Q1 2018 | share | Decrease | -2.86% | -12.08K shares | 481K | $56.4 | 410.49K |
| Q4 2017 | share | Decrease | -1.52% | -6.51K shares | 1.22M | $53.46 | 422.57K |
| Q3 2017 | share | Decrease | -0.91% | -3.93K shares | 1.84M | $49.74 | 429.08K |
| Q2 2017 | share | Decrease | -1.84% | -8.13K shares | 1.45M | $45.07 | 433.02K |
| Q1 2017 | share | Decrease | -0.73% | -3.22K shares | 2.52M | $40.93 | 441.16K |
| Q4 2016 | share | Decrease | -1.83% | -8.30K shares | -2.07M | $35.17 | 444.38K |
| Q3 2016 | share | Increase | +1.03% | 4.62K shares | 1.53M | $38.48 | 452.68K |
| Q2 2016 | share | Decrease | -5.63% | -26.74K shares | -2.24M | $35.55 | 448.06K |
| Q1 2016 | share | Increase | +9.49% | 41.16K shares | 386K | $37.6 | 474.81K |